5.3 Substance Use, Abuse, and Prevention

Substance Use, Abuse & Prevention

Substance use education is a foundational component of comprehensive school health programs. Health educators must possess a deep understanding of pharmacology, addiction neurobiology, ecological risk factors, and evidence-based prevention models to effectively educate students and reduce adolescent risk behaviors.

Pharmacological Classifications and Physiological Mechanisms

Psychoactive substances interact with the central nervous system (CNS) by altering neurotransmitter production, release, reuptake, or receptor binding. They are categorized based on their primary physiological and psychological effects.

Central Nervous System Depressants

CNS depressants slow down neural activity, heart rate, respiration, and brain function. Key examples include:

• Alcohol (Ethanol): Enhances gamma-aminobutyric acid (GABA) activity, an inhibitory neurotransmitter, while inhibiting glutamate (an excitatory neurotransmitter). This leads to impaired motor coordination, slowed reaction times, reduced inhibitions, and cognitive depression. Blood Alcohol Concentration (BAC) measures the percentage of alcohol in the bloodstream (e.g., 0.08% is the legal limit for adult drivers in most U.S. states, though zero-tolerance laws apply to underage youth).
• Prescription Opioids & Illicit Narcotics: Substances such as oxycodone, hydrocodone, morphine, heroin, and synthetic fentanyl bind to mu-opioid receptors in the brain and spinal cord, blocking pain signals and triggering massive dopamine release. Fentanyl, a synthetic opioid 50 to 100 times more potent than morphine, poses extreme lethal overdose risks due to rapid respiratory depression. Naloxone (Narcan) is a competitive opioid antagonist that reverses overdose by displacing opioids from receptor sites.
• Sedatives and Anxiolytics: Benzodiazepines (e.g., alprazolam, diazepam) and barbiturates enhance GABA binding, causing sedation, muscle relaxation, and reduced anxiety. Combining depressants (e.g., alcohol with opioids or benzodiazepines) causes synergistic respiratory depression, frequently resulting in fatal overdose.

Central Nervous System Stimulants

Stimulants accelerate CNS activity, increasing heart rate, blood pressure, metabolic rate, and alertness.

• Nicotine & E-Cigarettes (Vaping): Nicotine binds to nicotinic acetylcholine receptors in the brain, triggering adrenaline release and dopamine surges. Electronic cigarettes and vaping devices deliver aerosolized nicotine, flavorings, and heavy metals (e.g., nickel, tin, lead). Adolescent exposure to nicotine damages the developing prefrontal cortex—the region controlling impulse control, executive function, and attention. E-cigarette or Vaping Use-Associated Lung Injury (EVALI) represents an acute inflammatory pulmonary response often linked to vitamin E acetate and toxic aerosol constituents.
• Cocaine and Amphetamines: Cocaine blocks the reuptake of dopamine, norepinephrine, and serotonin. Amphetamines (including prescription ADHD stimulants like methylphenidate and dextroamphetamine when misused) force excess release of these monoamines. Chronic use causes severe cardiovascular stress, paranoia, hyperthermia, and neurotoxic depletion of natural dopamine reserves.

Cannabis and Hallucinogens

• Cannabis (Marijuana): Delta-9-tetrahydrocannabinol (THC) binds to cannabinoid receptors (CB1 in the brain, CB2 in the immune system), altering perception, mood, short-term memory, and motor coordination. Cannabidiol (CBD) is a non-intoxicating cannabinoid with distinct therapeutic profiles. High-potency THC products pose risks for adolescent cognitive development, persistent memory deficits, and triggering underlying psychotic disorders in vulnerable individuals.
• Hallucinogens/Psychedelics: Lysergic acid diethylamide (LSD), psilocybin, and ecstasy (MDMA) alter serotonin pathways, causing perceptual distortions, synesthesia, and emotional lability. Dissociative drugs like phencyclidine (PCP) and ketamine block NMDA glutamate receptors, causing feeling of detachment from reality.

Pharmacological Summary Table

Stages of Addiction & The Bio-Psychosocial Model

Addiction is recognized by medical organizations as a chronic, relapsing brain disorder characterized by compulsive substance seeking despite harmful consequences. Substance use disorders (SUD) progress along a continuum:

1. Experimental Use: Initial curiosity-driven or peer-influenced sampling of a substance, typically motivated by novelty or social fitting.
2. Regular / Social Use: Patterned use integrated into specific social contexts without significant functional impairment.
3. Problematic Misuse / Abuse: Continued use despite negative consequences (e.g., declining academic performance, interpersonal conflicts, risky behaviors like driving while intoxicated).
4. Chemical Dependence / Addiction: Chronic stage marked by compulsive craving, neurochemical rewiring of the brain's reward pathway (nucleus accumbens and ventral tegmental area), and:
   • Tolerance: Neuroadaptation requiring larger doses of the substance to achieve the initial physiological or psychological effect.
   • Withdrawal: Physical and psychological distress symptoms occurring when substance administration is abruptly reduced or stopped (e.g., delirium tremens in severe alcohol withdrawal, intense body aches and severe nausea in opioid withdrawal).

Risk and Protective Factors: The Ecological Framework

Substance use behaviors develop within a complex ecological web of individual, interpersonal, school, and community influences.

Risk Factors

• Individual / Biological: Family history of addiction (genetic vulnerability accounting for 40-60% of SUD risk), early age of first use (prior to age 15), co-occurring mental health conditions (e.g., depression, anxiety, ADHD), adverse childhood experiences (ACEs), and impulse control deficits.
• Interpersonal / Family: Parental substance use, lack of parental supervision, conflictual home environment, and association with substance-using peers.
• School & Community: Low academic commitment, school failure, easy commercial access to alcohol/vaping products, poverty, and favorable community norms toward drug use.

Protective Factors

• Individual: High emotional self-regulation, strong problem-solving skills, belief in self-efficacy, and personal anti-drug attitudes.
• Interpersonal / Family: Strong family bond, clear parental expectations and consistent discipline, open communication, and supportive adult role models.
• School & Community: Positive school connectedness, opportunities for prosocial involvement, strict anti-substance policies, and community-wide prevention coalitions.

Evidence-Based School Prevention Strategies

Historically, school drug prevention relied on ineffective scare tactics, exaggerated horror stories, or passive lectures (such as legacy assembly programs). Rigorous evaluation research has demonstrated that these approaches do not produce sustained behavior change.

Tiered Prevention Framework

• Universal Prevention: Delivered to the entire student population (e.g., school-wide health education curricula) to prevent or delay the onset of substance use.
• Selective Prevention: Targeted at specific sub-groups of students who exhibit heightened risk factors (e.g., support groups for children of individuals with alcohol use disorder).
• Indicated Prevention: Designed for individual students already engaging in early substance experimentation or exhibiting warning signs, aimed at stopping progression to addiction.

Key Components of Effective Curricula

Evidence-based programs (such as LifeSkills Training or Botvin LifeSkills) incorporate:

1. Interactive Pedagogy: Role-playing, small group discussion, and behavioral rehearsal rather than passive lecture.
2. Normative Education: Correcting exaggerated student perceptions regarding peer drug use. Adolescents routinely overestimate how many of their peers smoke, drink, or vape; presenting accurate local survey data reduces social pressure.
3. Personal and Social Competence Training: Teaching decision-making, stress management, media literacy, and emotional regulation.
4. Refusal Skill Instruction: Teaching specific, assertive communication techniques to resist peer pressure without escalating social conflict.